Search research articles
Contact Us
Filters
Showing results (351-360 of 386) with videos related to
Page
of 39
Sort By:
The Lancet. Oncology
|
September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group
Nancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
Neuro-Oncology
|
December 26, 2024
The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma
Macarena I de la Fuente, Mehdi Touat, Martin J van den Bent, et al.
Neuro-Oncology
|
April 28, 2025
Establishing the content validity of Patient-Reported Outcome measures used in neuro-oncology based on the WHO ICF framework: part of the RANO-PRO initiative
Ogechukwu A Asogwa, Linda Dirven, Tobias Walbert, et al.
Neuro-Oncology
|
October 25, 2025
Associations of supramaximal resection with outcome in glioblastoma across age groups: a report of the RANO resect group
Nico Teske, Antonio Dono, Jacob S Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2012
SSBP2 variants are associated with survival in glioblastoma patients
Yuanyuan Xiao, Paul A Decker, Terri Rice, et al.
Neuro-Oncology
|
April 8, 2022
Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes
Yalan Zhang, Calixto-Hope G Lucas, Jacob S Young, et al.
The Lancet. Oncology
|
June 13, 2015
Response assessment criteria for brain metastases: proposal from the RANO group
Nancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
Neuro-Oncology Advances
|
May 19, 2021
The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment
Maciej M Mrugala, Quinn T Ostrom, Shelley M Pressley, et al.
Cell
|
January 19, 2024
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective
Radhika Mathur, Qixuan Wang, Patrick G Schupp, et al.
Nature
|
February 19, 2025
Tumour-wide RNA splicing aberrations generate actionable public neoantigens
Darwin W Kwok, Nicholas O Stevers, Iñaki Etxeberria, et al.
Page
of 39
Search research articles
Search
Showing results (351-360 of 386) with videos related to
Sort By:
Page
of 39
The Lancet. Oncology
|
September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group
Nancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
Neuro-Oncology
|
December 26, 2024
The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma
Macarena I de la Fuente, Mehdi Touat, Martin J van den Bent, et al.
Neuro-Oncology
|
April 28, 2025
Establishing the content validity of Patient-Reported Outcome measures used in neuro-oncology based on the WHO ICF framework: part of the RANO-PRO initiative
Ogechukwu A Asogwa, Linda Dirven, Tobias Walbert, et al.
Neuro-Oncology
|
October 25, 2025
Associations of supramaximal resection with outcome in glioblastoma across age groups: a report of the RANO resect group
Nico Teske, Antonio Dono, Jacob S Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2012
SSBP2 variants are associated with survival in glioblastoma patients
Yuanyuan Xiao, Paul A Decker, Terri Rice, et al.
Neuro-Oncology
|
April 8, 2022
Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes
Yalan Zhang, Calixto-Hope G Lucas, Jacob S Young, et al.
The Lancet. Oncology
|
June 13, 2015
Response assessment criteria for brain metastases: proposal from the RANO group
Nancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
Neuro-Oncology Advances
|
May 19, 2021
The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment
Maciej M Mrugala, Quinn T Ostrom, Shelley M Pressley, et al.
Cell
|
January 19, 2024
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective
Radhika Mathur, Qixuan Wang, Patrick G Schupp, et al.
Nature
|
February 19, 2025
Tumour-wide RNA splicing aberrations generate actionable public neoantigens
Darwin W Kwok, Nicholas O Stevers, Iñaki Etxeberria, et al.
Page
of 39